Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Therapy for Carcinoma in Situ of the Bladder
Author:
Affiliation:
1. Department of Urology, Helsinki University Central Hospital, Helsinki, Finland.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference22 articles.
1. Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients.;Huland;Eur. Urol.,1983
2. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.;Herr;J. Urol.,1986
3. Long-term results of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer.;Sarosdy;J. Urol.,1989
4. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder.;Lamm;New Engl. J. Med.,1991
5. Intravesical chemotherapy (mitomycin C) versus immunotherapy (bacillus Calmette-Guerin) in superficial bladder cancer.;Rintala;Eur. Urol.,1991
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy Study of Mitomycin C Pre-infusion in Addition to Periodic Bacillus Calmette-Guerin Infusions in the Management of Non-muscle Invasive Bladder Cancers;Journal of Urological Surgery;2021-12-01
2. Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer;Cochrane Database of Systematic Reviews;2020-01-08
3. BCG Versus Mitomycin C—A Systematic Review;Management of Non-Muscle Invasive Bladder Cancer;2019-10-24
4. Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis;Frontiers in Oncology;2019-03-01
5. Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment;Oncology Reports;2019-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3